← All Insights · Macro Sep 13, 2026 · 7 min read CIN Terminal · Synthesized from live signals · Sep 13, 2026 07:23 UTC HoldCIN Rating 60/100How is this calculated? TLRY Sets the Global Cannabis Macro Test Tilray’s fiscal 2027 outlook puts cash conversion—not headline EBITDA or policy optionality—at the center of global cannabis positioning. Key takeaways Share X LinkedIn Email Copy link Found this useful? Share it X LinkedIn More like this, straight to your inbox One new CIN Insight + the week's top three signals from the live terminal. Free, weekly. Subscribe Related Insights